Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Moisten a cotton ball with rubbing alcohol and use it to wipe the skin at the injection site
Andrea Corona MapLight reports mixed results in Schizophrenia trial In their Phase 2 ZEPHR trial, MapLights novel oral drug for schizophrenia, the Ml/M4 muscarinic agonist ML-007C-MA, successfully hit its primary endpoint but only for the twice-daily version, not the once-daily dose
Third-party COA: Look for HPLC purity testing per batch from an independent ISO/IEC 17025-accredited lab
The current study focused on summarizing the mechanism of action of GPX3 in OC and OCSCs, as well as identifying potential targets for clinical intervention
